Standard Biotools Stock Technical Analysis
| LAB Stock | USD 0.93 -0.04 -4.12% |
As of the 14th of March 2026, Standard Biotools trades at 0.93 per share. Key technical indicators include Risk Adjusted Performance of -0.10, variance of 18.42, and Coefficient Of Variation of -722.78. The technical model evaluates historical price movement, trading volume, and volatility patterns to quantify trend strength. With a price below $1.00, liquidity and volatility metrics receive additional emphasis. Current values are evaluated relative to sector peers and historical ranges.
Standard Biotools Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Standard, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to StandardStandard Biotools' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 1.55 | Strong Buy | 3 | Odds |
Standard Biotools current and past analyst recommendations are summarized from multiple research sources. The view also includes average analyst consensus. Most Standard analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Standard stock's fair price compared to its market value.
Earnings Share -0.15 | Revenue Per Share | Quarterly Revenue Growth -0.14 | Return On Assets | Return On Equity |
The market value of Standard Biotools is measured differently than book value, which reflects Standard accounting equity. Standard Biotools' market capitalization is 358.65 M. A P/B ratio of 0.85 suggests Standard Biotools trades near or below book value. Enterprise value stands at 201.9 M. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Valuation methods compare these perspectives to frame context.
Note that Standard Biotools' intrinsic value and market price are different measures derived from different inputs. For Standard Biotools, key inputs include a P/B ratio of 0.85, a profit margin of -87.77%, ROE of -13.13%, and revenue of 85.33 M. By contrast, market price reflects the level where buyers and sellers transact.
What if' Analysis
Running a what-if backtest on Standard Biotools gives investors a practical way to test how changes in horizon, position size, or market timing might have affected the result. Used properly, this review helps investors decide whether Standard Biotools' historical reward profile was stable enough to support the current thesis.
| 12/14/2025 |
| 03/14/2026 |
If you invested 0.00 in Standard Biotools on December 14, 2025 and closed the position today, you would earn 0.00 in total gains. That corresponds to a 0.0% return on investment in Standard Biotools overall over 90 days. Standard Biotools is related to or competes with Varex Imaging, CeriBell, Cullinan Oncology, Avanos Medical, So Young, ADC Therapeutics, and Treace Medical. Peer context helps frame relative positioning. Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researche... More
Standard Biotools Upside and Downside Indicators Overview
Upside and downside indicators for Standard Biotools summarize momentum balance and potential range context for the stock. They compare current price to recent trend and sentiment readings.
| Information Ratio | -0.13 | |||
| Maximum Drawdown | 27.04 | |||
| Value At Risk | -6.12 | |||
| Potential Upside | 7.1 |
Standard Biotools Market Risk Indicators Overview
Market risk indicators summarize volatility and return dispersion for Standard Biotools. The metrics rely on historical prices to describe variability over time.| Risk Adjusted Performance | -0.10 | |||
| Jensen Alpha | -0.52 | |||
| Total Risk Alpha | -0.36 | |||
| Treynor Ratio | -0.33 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Standard Biotools' price to converge to an average value over time is called mean reversion.
Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | -0.10 | |||
| Market Risk Adjusted Performance | -0.32 | |||
| Mean Deviation | 2.87 | |||
| Coefficient Of Variation | -722.78 | |||
| Standard Deviation | 4.29 | |||
| Variance | 18.42 | |||
| Information Ratio | -0.13 | |||
| Jensen Alpha | -0.52 | |||
| Total Risk Alpha | -0.36 | |||
| Treynor Ratio | -0.33 | |||
| Maximum Drawdown | 27.04 | |||
| Value At Risk | -6.12 | |||
| Potential Upside | 7.1 | |||
| Skewness | 1.85 | |||
| Kurtosis | 8.1 |
Standard Biotools Backtested Returns
Standard Biotools appears to exhibit an extremely high risk exposure over the selected 3 months investment horizon. It records an Efficiency (Sharpe) Ratio of -0.16, indicating negative risk-adjusted returns over the last 3 months. Volatility modeling revealed twenty-three technical measures impacting risk exposure. Please review metrics such as Coefficient Of Variation of -722.78, risk-adjusted performance of -0.10, and Variance of 18.42 to confirm whether our risk estimates align with your expectations. The company has a beta of 1.83, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Standard Biotools will likely underperform. At this point, Standard Biotools has a negative expected return of -0.7%. Please make sure to check Standard Biotools' the relationship between the jensen alpha and value at risk, to decide if Standard Biotools's performance from the past will be repeated at some future point.
Auto-correlation | 0.12 |
Insignificant predictability
Serial correlation analysis for Standard Biotools reveals insignificant predictability across the intervals from 14th of December 2025 to 28th of January 2026 and from 28th of January 2026 to 14th of March 2026. The degree of alignment between past and current intervals shapes expectations about Standard Biotools's price persistence. At 0.12, less than 12.0% of current Standard Biotools price movement aligns with historical price trajectory.
| Correlation Coefficient | 0.12 | |
| Spearman Rank Test | -0.21 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Standard Biotools technical stock analysis uses price and volume transformations to study behavior. Typical tools include moving averages, relative strength index, regressions, and price correlations.
Technical Analysis
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Standard Biotools volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Technical Analysis Methodology & Indicators
Technical analysis of Standard Biotools evaluates price structure, momentum, and volatility clustering. Trend persistence provides context for directional stability. Market-sensitive characteristics may increase exposure to broader economic cycles. Standard Biotools has a market cap of 358.65 M, ROE of -13.13%.
Unless otherwise specified, data for Standard Biotools is compiled from periodic company reporting and market reference feeds and standardized for comparability. Updates may occur throughout the day.
This content is curated and reviewed by:
Gabriel Shpitalnik - Member of Macroaxis Editorial BoardStandard Biotools Technical Indicators
A technical review of Standard Biotools can improve timing discipline by comparing momentum, reversal risk, and confirmation signals across several time horizons. The stronger process confirms one signal with others instead of reacting to one pattern in isolation.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | -0.10 | |||
| Market Risk Adjusted Performance | -0.32 | |||
| Mean Deviation | 2.87 | |||
| Coefficient Of Variation | -722.78 | |||
| Standard Deviation | 4.29 | |||
| Variance | 18.42 | |||
| Information Ratio | -0.13 | |||
| Jensen Alpha | -0.52 | |||
| Total Risk Alpha | -0.36 | |||
| Treynor Ratio | -0.33 | |||
| Maximum Drawdown | 27.04 | |||
| Value At Risk | -6.12 | |||
| Potential Upside | 7.1 | |||
| Skewness | 1.85 | |||
| Kurtosis | 8.1 |
March 14, 2026 Daily Trend Indicators
A technical review of Standard Biotools can improve timing discipline by comparing momentum, reversal risk, and confirmation signals across several time horizons. The stronger process confirms one signal with others instead of reacting to one pattern in isolation.
| Accumulation Distribution | 0.04 | ||
| Daily Balance Of Power | -1.00 | ||
| Rate Of Daily Change | 0.96 | ||
| Day Median Price | 0.94 | ||
| Day Typical Price | 0.94 | ||
| Price Action Indicator | -0.03 | ||
| Market Facilitation Index | 0.04 |
Popular Tools for Standard Stock analysis
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |